-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, according to the information waiting for receipt of the drug approval documents published on the official website of the State Food and Drug Administration, a total of 12 generic drugs have passed the consistency evaluation.
Granisetron Hydrochloride Injection
Granisetron Hydrochloride InjectionGranisetron Hydrochloride Injection is a selective 5-HT3 receptor antagonist, which is mainly used clinically for the prevention and treatment of nausea and vomiting caused by radiotherapy, chemotherapy and surgery.
At present, there are currently as many as 29 domestic manufacturers with valid approval document numbers for this product.
PharmaGo
PharmaGoCimetidine Tablets
Cimetidine TabletsCimetidine tablets are histamine H2 receptor resistance agents and are mainly used clinically to treat duodenal ulcer, gastric ulcer, reflux esophagitis, stress ulcer and Zollinger-Ellison syndrome , Is an OTC (over-the-counter drug) product.
PharmaGo
PharmaGoTranexamic acid injection
Tranexamic acid injectionTranexamic acid is an antifibrinolytic agent, which is clinically used to treat various hemorrhages caused by acute or chronic, localized or systemic primary fibrinolysis hyperplasia.
PharmaGo
PharmaGoIn addition, Yangtze River, Hunan Seron, Shanxi Pude Pharmaceutical, and Chengdu Lier Pharmaceutical also applied for consistency evaluation of the product.
